Through integrated network analysis and clinical transcriptomic data, we identified five core targets (EGFR, JAK1, JAK2, PTPN11, and SRD5A1) that are differentially expressed in ovarian cancer tissues and serve as central nodes in TWP’s mechanism of action. This evidence concerns the gene JAK1 and ovarian carcinoma.